Bridgette J. Connell

Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa

Bridgette J. Connell, Katherine Michler, Alexio Capovilla et al. · AIDS · 2008 · 58 citations

Life Sciences, Infectious Diseases, Molecular Epidemiology +14

A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation

Bridgette J. Connell, Sui‐Yuan Chang, Ekambaranellore Prakash et al. · PLoS ONE · 2016 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection

Bridgette J. Connell, Lucas E. Hermans, Annemarie M. J. Wensing et al. · Scientific Reports · 2020 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4

Bridgette J. Connell, Rabia Sadir, Françoise Baleux et al. · Science Signaling · 2016 · 34 citations

Life Sciences, Cell Biology, Molecular Biology +16

CCR5 structural plasticity shapes HIV-1 phenotypic properties

Philippe Colin, Zhicheng Zhou, Isabelle Staropoli et al. · PLoS Pathogens · 2018 · 34 citations · Full text

Life Sciences, Biology, Molecular Biology +17